SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-040856
Filing Date
2024-05-08
Accepted
2024-05-08 16:06:11
Documents
50
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0203670-10q_relmada.htm   iXBRL 10-Q 386208
2 CERTIFICATION ea020367001ex31-1_relmada.htm EX-31.1 11314
3 CERTIFICATION ea020367001ex31-2_relmada.htm EX-31.2 10807
4 CERTIFICATION ea020367001ex32-1_relmada.htm EX-32.1 6024
5 CERTIFICATION ea020367001ex32-2_relmada.htm EX-32.2 4345
  Complete submission text file 0001213900-24-040856.txt   3062454

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rlmd-20240331.xsd EX-101.SCH 31345
7 XBRL CALCULATION FILE rlmd-20240331_cal.xml EX-101.CAL 22641
8 XBRL DEFINITION FILE rlmd-20240331_def.xml EX-101.DEF 164688
9 XBRL LABEL FILE rlmd-20240331_lab.xml EX-101.LAB 298206
10 XBRL PRESENTATION FILE rlmd-20240331_pre.xml EX-101.PRE 162403
54 EXTRACTED XBRL INSTANCE DOCUMENT ea0203670-10q_relmada_htm.xml XML 231089
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39082 | Film No.: 24925877
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)